Immunic reported $40.7M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Alterity Therapeutics Limited AUD 27.32M 6.07M Jun/2023
BioMarin Pharmaceutical USD 7.59B 20.85M Dec/2025
Cipla INR 401.64B 27.77B Sep/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 97.84M 8.68M Sep/2025
CSL USD 37.9B 1.5B Dec/2025
Enanta Pharmaceuticals USD 329.5M 48.77M Dec/2025
Grifols EUR 23.29B 3.35M Sep/2025
Immunic USD 40.7M 20.72M Sep/2025
Insmed USD 2.26B 96.18M Dec/2025
Omeros USD 200.57M 34.59M Jun/2025
OraSure Technologies USD 423.1M 21.94M Sep/2025
Quidel USD 5.77B 94.2M Dec/2025
Ultragenyx Pharmaceutical USD 1.53B 341.56M Dec/2025
United Therapeutics USD 7.88B 528.9M Dec/2025
Xoma USD 263.15M 39.7M Sep/2025